- Abstract
Targeting Melanoma via Drug Repurposing: Investigating Melatonin Synergy and Melanin-Driven Resistance in 2D Cell Line Models
- Eliza Szabo and
- Iulia Andreea Pinzaru
Melanoma is a highly aggressive form of skin cancer known for its swift acquisition of resistance to treatment, particularly therapies targeting the Mitogen-Activated Protein Kinase (MAPK) signaling cascade [...]
14 October 2025